Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 11, 2010

View Archived Issues

Preclinical and clinical data reported on yellow fever vaccine XRX-001

TG-003 may be beneficial in Duchenne's muscular dystrophy

V-211 vaccine reduces incidence of shingles in adults aged 50-59 years in phase III trial

RO-2492 alleviates symptoms of collagen-induced arthritis in mice

Fosfomycin/tobramycin improves lung function in patients with CF and lung infections

Omeros identifies GPR87 receptor antagonist that potentiates doxorubicin activity

Pfizer offers overview of third quarter 2010

Biovista and Pfizer partner to identify new indications for Pfizer drug candidates

Merck & Co. reviews quarterly developments

Pfizer begins phase I trial of PF-05230905

Palatin Technologies receives grants from U.S. government to support development of four projects

Merck & Co. describes new phosphodiesterase 10A inhibitors

Novartis presents new HCV NS3/NS4A inhibitors

Bristol-Myers Squibb discovers new inhibitors of HCV NS5A

Actelion Pharma discloses new P2Y12 receptor antagonists

Pozen projects are selected for federal grant funding

Merck KGaA patents new E-NPP 2 inhibitors

NeuroDerm advances phase IIa trial of ND-0801 in ADD/ADHD

Upsher-Smith Labs begins extension study of USL-255 for partial-onset epilepsy

Schering-Plough Europe withdraws MAA for Zenhale

Eusa Pharma submits BLA to FDA for Erwinase in acute lymphoblastic leukemia

Michael J. Fox Foundation awards grant to Acadia Pharma

FDA fast track status for Sanofi Pasteur's C. difficile vaccine CdAB

SuperGen discontinues development of SGI-1776 due to toxicity results

Watson Pharma plans to discontinue development of Uracyst

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...